‌

US Patent 10806785 Immunomodulator compounds and methods of use

Patent 10806785 was granted and assigned to Incyte on October, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Date of Patent

October 20, 2020

0

Patent Application Number

158514970

Date Filed

December 21, 2017

0

Patent Citations

US Patent 10308644 Heterocyclic compounds as immunomodulators

US Patent 10202343 MIF modulators

US Patent 10017520 Myc modulators and uses thereof

Patent Citations Received

US Patent 12084443 Process of preparing a PD-1/PD-L1 inhibitor

0

US Patent 11535615 Heterocyclic compounds as immunomodulators

0

US Patent 11873309 Heterocyclic compounds as immunomodulators

0

US Patent 12059470 Formulated and/or co-formulated liposome compositions containing PD-1 antagonist prodrugs useful in the treatment of cancer and methods thereof

0

US Patent 11465981 Heterocyclic compounds as immunomodulators

US Patent 11566026 Heterocyclic compounds as immunomodulators

US Patent 11572366 Heterocyclic compounds as immunomodulators

US Patent 11608337 Heterocyclic compounds as immunomodulators

0

...

Patent Primary Examiner

Angela C Brown-Pettigrew

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10806785 Immunomodulator compounds and methods of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.